Insmed
INSM
#677
Rank
A$50.80 B
Marketcap
A$235.71
Share price
-1.47%
Change (1 day)
104.01%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.83 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.60 Billion. a decrease over its 2024 earnings that were of -A$1.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.74 Billion43.91%
2024 -A$1.21 Billion23.71%
2023 -A$0.98 Billion45.77%
2022 -A$0.67 Billion15.83%
2021 -A$0.58 Billion50.19%
2020 -A$0.39 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.44 Billion59.35%
2017 -A$0.28 Billion8.52%
2016 -A$0.26 Billion47.25%
2015 -A$0.18 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$79.64 Million35.14%
2012 -A$58.94 Million-31.92%
2011 -A$86.57 Million854.92%
2010 -A$9.07 Million-105.22%
2009 A$0.17 B-905.06%
2008 -A$21.56 Million-27.31%
2007 -A$29.66 Million-62.41%
2006 -A$78.91 Million98.19%
2005 -A$39.82 Million0.03%
2004 -A$39.8 Million159.07%
2003 -A$15.37 Million-69.31%
2002 -A$50.06 Million
2000 -A$45.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.72 B-1,469.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$14.21 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.75 B-489.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.37 Billion-78.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.73 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.39 M-100.37%๐Ÿ‡บ๐Ÿ‡ธ USA